{"instance_id": "ws_en_019", "response": "```markdown\n| Company Name       | Listing Board                       | Bloomberg ticker | Listing Date | Initial Offering Price(per share) | Total Funds Raised in 2024(million) | Revenue in 2024(million) | Net Income Attributable to Shareholders(million) | R&D Expenses(million) |\n|--------------------|-------------------------------------|------------------|--------------|-----------------------------------|-------------------------------------|--------------------------|--------------------------------------------------|-----------------------|\n| CG Oncology         | Nasdaq Global Select Market         | CGON             | 2024/01/25   | 16.00                             | 437.00                              | 1.13                     | -31.80                                          | 82.10                 |\n| Zenas BioPharma     | Nasdaq Global Select Market         | ZBIO             | 2024/09/13   | 17.00                             | 225.00                              | 5.00                     | -38.60                                          | 33.50                 |\n| Upstream Bio        | Nasdaq Global Select Market         | UPB              | 2024/10/11   | 17.00                             | 293.00                              | 2.37                     | -21.20                                          | 15.40                 |\n| MBX Biosciences     | Nasdaq Global Select Market         | MBX              | 2024/09/13   | 16.00                             | 251.20                              | 0.00                     | -15.60                                          | 57.40                 |\n| Metagenomi          | Nasdaq Global Select Market         | MGX              | 2024/02/09   | 17.00                             | 157.00                              | 52.30                    | -61.92                                          | 109.20                |\n```"}
